Trial
NCT03211988
Entinostat Neuroendocrine (NE) Tumor
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Antonio Fojo
Collaborators
—
Condition
Neuroendocrine Tumors
Intervention
Entinostat
Why stopped
Lack of funding and drug supply
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-02